Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for James E Besser. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at James E Besser har rapporteret besiddelser eller handler i følgende virksomheder:
Sikkerhed | Titel | Senest indberettede beholdninger |
---|---|---|
US:MODD / Modular Medical, Inc. | Chief Executive Officer, 10% Owner | 422.000 |
US:SNWV / SANUWAVE Health, Inc. | 52.653 | |
US:BRSF / Brain Scientific Inc. | 10% Owner | 19.545.187 |
US:PCSA / Processa Pharmaceuticals, Inc. | 10% Owner | 1.096.071 |
US:NMTC / NeuroOne Medical Technologies Corporation | 10% Owner | 492.951 |
US:FIEE / FiEE, Inc. | 10% Owner | 0 |
US:CLOK / SideChannel Inc | 10% Owner | 4.261.000 |
US:MFST / Medifirst Solutions Inc | 10% Owner | 696.612 |
US:FENC / Fennec Pharmaceuticals Inc. | 10% Owner | 1.324.794 |
US:NTS / Nts, Inc. | 10% Owner | 824.057 |
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af James E Besser. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb BRSF / Brain Scientific Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg BRSF / Brain Scientific Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb FENC / Fennec Pharmaceuticals Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg FENC / Fennec Pharmaceuticals Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb FIEE / FiEE, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg FIEE / FiEE, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb MODD / Modular Medical, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg MODD / Modular Medical, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb NMTC / NeuroOne Medical Technologies Corporation – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg NMTC / NeuroOne Medical Technologies Corporation – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb PCSA / Processa Pharmaceuticals, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2020-10-02 | PCSA | BESSER JAMES E | 30.000 | 4,0400 | 1.500 | 80,8000 | 121.200 | 167 | 263 | 273.300 | 225,50 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg PCSA / Processa Pharmaceuticals, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SDCH / SideChannel, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SDCH / SideChannel, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SNWV / SANUWAVE Health, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i BRSF / Brain Scientific Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Maks |
Pris kl Maks |
Maks Fortjeneste ($) |
Maks. afkast (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-18 | SNWV | MANCHESTER MANAGEMENT CO LLC | 181.818 | 8,2500 | 485 | 3.093,7500 | 1.499.998 | 308 | 45.0000 | -1.478.218 | -98,55 |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SNWV / SANUWAVE Health, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i BRSF / Brain Scientific Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af James E Besser som oplyst til Securities Exchange Commission (SEC).
Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-24 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 156.250 | 422.000 | 58,80 | 1,92 | 300.000 | 810.240 | |
2025-03-24 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 520.832 | 3.805.575 | 15,86 | 1,92 | 999.997 | 7.306.704 | |
2024-12-04 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 21.000 | 265.750 | 8,58 | 1,68 | 35.236 | 445.902 | |
2024-11-29 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 100.000 | 244.750 | 69,08 | 1,69 | 168.950 | 413.505 | |
2024-11-25 |
|
4/A | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 900.000 | 3.118.077 | 40,58 | 1,10 | 990.000 | 3.429.885 | |
2024-11-25 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 166.666 | 3.284.743 | 5,35 | 1,50 | 249.999 | 4.927.114 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 14.167 | 52.653 | 36,81 | 25,13 | 356.017 | 1.323.170 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 15.000 | 38.486 | 63,87 | 15,00 | 225.000 | 577.290 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 22.667 | 83.999 | 36,96 | 25,13 | 569.622 | 2.110.895 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 24.000 | 61.332 | 64,29 | 15,00 | 360.000 | 919.980 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
P - Purchase | 181.818 | 1.006.790 | 22,04 | 8,25 | 1.499.998 | 8.306.018 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 6.375 | 824.971 | 0,78 | 25,13 | 160.204 | 20.731.521 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 42.498 | 818.596 | 5,48 | 25,13 | 1.067.975 | 20.571.317 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 6.750 | 776.098 | 0,88 | 15,00 | 101.250 | 11.641.470 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 44.998 | 769.348 | 6,21 | 15,00 | 674.970 | 11.540.220 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 8.625 | 724.350 | 1,21 | 15,00 | 129.375 | 10.865.250 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 57.498 | 715.725 | 8,74 | 15,00 | 862.470 | 10.735.875 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 5.667 | 658.227 | 0,87 | 25,13 | 142.412 | 16.541.245 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 6.000 | 652.560 | 0,93 | 15,00 | 90.000 | 9.788.400 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 7.667 | 646.560 | 1,20 | 15,00 | 115.005 | 9.698.400 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 17.000 | 638.893 | 2,73 | 25,13 | 427.210 | 16.055.381 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 18.000 | 621.893 | 2,98 | 15,00 | 270.000 | 9.328.395 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 141.667 | 603.893 | 30,65 | 25,13 | 3.560.092 | 15.175.831 | |
2024-10-23 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
J - Other | 150.000 | 462.226 | 48,04 | 15,00 | 2.250.000 | 6.933.390 | |
2024-05-13 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 8.625.000 | 117.085.646 | 7,95 | 0,04 | 345.000 | 4.683.426 | |
2024-02-21 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 900.000 | 3.118.227 | 40,57 | 1,10 | 990.000 | 3.430.050 | |
2023-11-21 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 11.500.000 | 14.000.000 | 460,00 | 0,04 | 460.000 | 560.000 | |
2023-10-18 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 20.000 | 144.750 | 16,03 | 1,10 | 21.974 | 159.037 | |
2023-10-18 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 13.000 | 330.473 | 4,09 | 1,04 | 13.549 | 344.419 | |
2023-08-09 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 10.442.806 | 11.942.806 | 696,19 | 0,04 | 417.712 | 477.712 | |
2023-08-09 |
|
4 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
C - Conversion | 71.875.000 | 108.460.646 | 196,46 | 0,04 | 2.875.000 | 4.338.426 | |
2022-08-10 | 3 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
|||||||||
2022-08-10 | 3 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
|||||||||
2022-08-10 | 3 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
|||||||||
2022-08-10 | 3 | SNWV |
SANUWAVE Health, Inc.
Common Stock, par value $0.001 |
|||||||||
2022-08-04 | 3 | BRSF |
BRAIN SCIENTIFIC INC.
Common Stock, $0.001 par value |
19.545.187 | ||||||||
2022-08-04 | 3 | BRSF |
BRAIN SCIENTIFIC INC.
Common Stock, $0.001 par value |
12.816.831 | ||||||||
2022-08-04 | 3 | BRSF |
BRAIN SCIENTIFIC INC.
Common Stock, $0.001 par value |
8.028.706 | ||||||||
2022-02-17 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock Purchase Warrant |
M - Exercise | 234.274 | 234.274 | |||||
2022-02-17 |
|
4 | MODD |
Modular Medical, Inc.
Convertible Promissory Note |
M - Exercise | -1.000.000 | 0 | -100,00 | ||||
2022-02-17 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
M - Exercise | 234.274 | 2.218.077 | 11,81 | ||||
2022-02-14 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock Purchase Warrant |
A - Award | 300.000 | 300.000 | |||||
2022-02-14 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 300.000 | 1.983.803 | 17,82 | 6,00 | 1.800.000 | 11.902.818 | |
2021-10-29 |
|
4/A | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 160.000 | 917.576 | 21,12 | 2,25 | 360.000 | 2.064.546 | |
2021-10-29 |
|
4/A | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 471.111 | 5.016.566 | 10,36 | 2,25 | 1.060.000 | 11.287.274 | |
2021-10-29 |
|
4/A | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 88.889 | 269.719 | 49,16 | 2,25 | 200.000 | 606.868 | |
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock Pur-chase Warrant |
A - Award | 379.174 | 379.174 | |||||
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Convertible Promissory Note |
A - Award | 1.000.000 | 1.000.000 | |||||
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Convertible Promissory Note |
D - Sale to Issuer | -1.000.000 | 0 | -100,00 | ||||
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Convertible Promissory Note |
P - Purchase | 1.000.000 | 1.000.000 | |||||
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 34.843 | 304.562 | 12,92 | 2,87 | 99.999 | 874.093 | |
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 104.529 | 1.022.105 | 11,39 | 2,87 | 299.998 | 2.933.441 | |
2021-10-29 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 34.843 | 5.051.409 | 0,69 | 2,87 | 99.999 | 14.497.544 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -20.929 | 1.096.071 | -1,87 | 11,56 | -241.939 | 12.670.581 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -3.000 | 1.117.000 | -0,27 | 11,20 | -33.600 | 12.510.400 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -5.000 | 1.120.000 | -0,44 | 11,35 | -56.750 | 12.712.000 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -400.000 | 648.300 | -38,16 | 10,76 | -4.304.000 | 6.975.708 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -16.000 | 1.048.300 | -1,50 | 10,67 | -170.720 | 11.185.361 | |
2021-05-05 |
|
4/A | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -31.771 | 1.064.300 | -2,90 | 10,91 | -346.622 | 11.611.513 | |
2021-04-08 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -400.000 | 648.300 | -38,16 | 10,76 | -4.304.000 | 6.975.708 | |
2021-04-08 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -16.000 | 1.048.300 | -1,50 | 10,67 | -170.720 | 11.185.361 | |
2021-04-08 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -31.771 | 1.064.300 | -2,90 | 10,91 | -346.622 | 11.611.513 | |
2021-02-22 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -20.929 | 1.096.071 | -1,87 | 11,56 | -241.939 | 12.670.581 | |
2021-02-22 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -3.000 | 1.117.000 | -0,27 | 11,20 | -33.600 | 12.510.400 | |
2021-02-22 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock, $0.01 par value |
S - Sale | -5.000 | 1.120.000 | -0,44 | 11,35 | -56.750 | 12.712.000 | |
2021-01-21 | 3 | NMTC |
NEUROONE MEDICAL TECHNOLOGIES Corp
Common Stock |
492.951 | ||||||||
2021-01-21 | 3 | NMTC |
NEUROONE MEDICAL TECHNOLOGIES Corp
Common Stock |
4.750.000 | ||||||||
2020-10-13 | 3 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock |
375.000 | ||||||||
2020-10-13 | 3 | PCSA |
Processa Pharmaceuticals, Inc.
Common Stock |
1.125.000 | ||||||||
2020-10-13 |
|
4 | PCSA |
Processa Pharmaceuticals, Inc.
Common Shares |
P - Purchase | 30.000 | 405.000 | 8,00 | 4,04 | 121.200 | 1.636.200 | |
2020-08-05 |
|
4 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
S - Sale | -142.857 | 0 | -100,00 | 1,95 | -278.571 | ||
2020-08-05 |
|
4 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
S - Sale | -143.357 | 0 | -100,00 | 1,95 | -279.546 | ||
2020-08-05 |
|
4 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
S - Sale | -2.857.643 | 0 | -100,00 | 1,95 | -5.572.404 | ||
2020-08-05 |
|
4 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
S - Sale | -4.287.214 | 0 | -100,00 | 1,95 | -8.360.067 | ||
2019-10-03 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 10.600 | 4.261.000 | 0,25 | 0,54 | 5.724 | 2.300.940 | |
2019-09-27 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 90.000 | 4.250.400 | 2,16 | 0,54 | 48.600 | 2.295.216 | |
2019-09-27 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 10.000 | 4.160.400 | 0,24 | 0,51 | 5.100 | 2.121.804 | |
2019-05-02 |
|
4 | MFST |
Medifirst Solutions, Inc.
Common Stock |
P - Purchase | 96.612 | 696.612 | 16,10 | 0,07 | 6.763 | 48.763 | |
2019-05-02 | 3 | MFST |
Medifirst Solutions, Inc.
Common Stock |
1.200.000 | ||||||||
2019-05-02 | 3 | MFST |
Medifirst Solutions, Inc.
Common Stock |
1.200.000 | ||||||||
2019-05-02 | 3 | MFST |
Medifirst Solutions, Inc.
Common Stock |
1.200.000 | ||||||||
2019-01-03 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 31.145 | 3.724.300 | 0,84 | 1,69 | 52.725 | 6.304.867 | |
2019-01-03 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 62.655 | 3.693.155 | 1,73 | 1,61 | 100.749 | 5.938.593 | |
2018-11-20 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 720.001 | 0 | -100,00 | 2,25 | 1.620.002 | ||
2018-11-01 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 11.100 | 3.656.600 | 0,30 | 1,81 | 20.091 | 6.618.446 | |
2018-11-01 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 15.000 | 3.645.500 | 0,41 | 1,88 | 28.200 | 6.853.540 | |
2018-10-30 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 15.500 | 3.630.500 | 0,43 | 1,84 | 28.520 | 6.680.120 | |
2018-10-30 |
|
4 | CLOK |
CIPHERLOC Corp
Common Shares |
P - Purchase | 15.000 | 3.615.000 | 0,42 | 1,85 | 27.750 | 6.687.750 | |
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-07-30 | 3 | CLOK |
CIPHERLOC Corp
Common Stock |
7.200.000 | ||||||||
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.324.794 | 0,04 | 2,23 | 1.115 | 2.954.291 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.324.794 | 0,04 | 2,23 | 1.115 | 2.954.291 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.500 | 1.324.294 | 0,19 | 2,23 | 5.575 | 2.953.176 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.500 | 1.324.294 | 0,19 | 2,23 | 5.575 | 2.953.176 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.321.794 | 0,04 | 2,53 | 1.265 | 3.344.139 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.321.794 | 0,04 | 2,53 | 1.265 | 3.344.139 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.500 | 1.321.294 | 0,42 | 2,34 | 12.870 | 3.091.828 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.500 | 1.321.294 | 0,42 | 2,34 | 12.870 | 3.091.828 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.315.794 | 0,53 | 2,40 | 16.800 | 3.157.906 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.315.794 | 0,53 | 2,40 | 16.800 | 3.157.906 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.308.794 | 0,15 | 2,50 | 5.000 | 3.271.985 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.308.794 | 0,15 | 2,50 | 5.000 | 3.271.985 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.306.794 | 0,46 | 2,68 | 16.080 | 3.502.208 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.306.794 | 0,46 | 2,68 | 16.080 | 3.502.208 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.300.794 | 0,02 | 2,76 | 828 | 3.590.191 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.300.794 | 0,02 | 2,76 | 828 | 3.590.191 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.300.494 | 0,77 | 2,50 | 25.000 | 3.251.235 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.300.494 | 0,77 | 2,50 | 25.000 | 3.251.235 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.290.494 | 0,05 | 2,72 | 1.632 | 3.510.144 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.290.494 | 0,05 | 2,72 | 1.632 | 3.510.144 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.967 | 1.289.894 | 0,31 | 2,56 | 10.156 | 3.302.129 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.967 | 1.289.894 | 0,31 | 2,56 | 10.156 | 3.302.129 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.285.927 | 0,02 | 2,69 | 807 | 3.459.144 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.285.927 | 0,02 | 2,69 | 807 | 3.459.144 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.285.627 | 0,04 | 2,68 | 1.340 | 3.445.480 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.285.627 | 0,04 | 2,68 | 1.340 | 3.445.480 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.666 | 1.285.127 | 0,13 | 2,46 | 4.098 | 3.161.412 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.666 | 1.285.127 | 0,13 | 2,46 | 4.098 | 3.161.412 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.586.899 | 0,01 | 2,32 | 232 | 3.681.606 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.586.899 | 0,01 | 2,32 | 232 | 3.681.606 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.586.799 | 0,44 | 2,30 | 16.100 | 3.649.638 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.586.799 | 0,44 | 2,30 | 16.100 | 3.649.638 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.579.799 | 0,06 | 2,23 | 2.230 | 3.522.952 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.579.799 | 0,06 | 2,23 | 2.230 | 3.522.952 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 15.700 | 1.578.799 | 1,00 | 2,59 | 40.663 | 4.089.089 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 15.700 | 1.578.799 | 1,00 | 2,59 | 40.663 | 4.089.089 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.425 | 1.563.099 | 0,16 | 2,36 | 5.723 | 3.688.914 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.425 | 1.563.099 | 0,16 | 2,36 | 5.723 | 3.688.914 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.560.674 | 0,02 | 2,45 | 735 | 3.823.651 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 300 | 1.560.674 | 0,02 | 2,45 | 735 | 3.823.651 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.560.374 | 0,32 | 2,45 | 12.250 | 3.822.916 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.560.374 | 0,32 | 2,45 | 12.250 | 3.822.916 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.000 | 1.555.374 | 0,71 | 2,02 | 22.220 | 3.141.855 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.000 | 1.555.374 | 0,71 | 2,02 | 22.220 | 3.141.855 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 20.000 | 1.544.374 | 1,31 | 1,92 | 38.400 | 2.965.198 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 20.000 | 1.544.374 | 1,31 | 1,92 | 38.400 | 2.965.198 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.100 | 1.524.374 | 0,67 | 1,67 | 16.867 | 2.545.705 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.100 | 1.524.374 | 0,67 | 1,67 | 16.867 | 2.545.705 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.000 | 1.514.274 | 0,73 | 1,63 | 17.930 | 2.468.267 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.000 | 1.514.274 | 0,73 | 1,63 | 17.930 | 2.468.267 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.503.274 | 0,20 | 1,67 | 5.010 | 2.510.468 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.503.274 | 0,20 | 1,67 | 5.010 | 2.510.468 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.000 | 1.500.274 | 0,27 | 2,10 | 8.400 | 3.150.575 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.000 | 1.500.274 | 0,27 | 2,10 | 8.400 | 3.150.575 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.800 | 1.496.274 | 0,32 | 1,98 | 9.504 | 2.962.623 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.800 | 1.496.274 | 0,32 | 1,98 | 9.504 | 2.962.623 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.300 | 1.491.474 | 0,29 | 1,84 | 7.912 | 2.744.312 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.300 | 1.491.474 | 0,29 | 1,84 | 7.912 | 2.744.312 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.000 | 1.487.174 | 0,61 | 1,77 | 15.930 | 2.632.298 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.000 | 1.487.174 | 0,61 | 1,77 | 15.930 | 2.632.298 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.478.174 | 0,07 | 1,75 | 1.750 | 2.586.804 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.478.174 | 0,07 | 1,75 | 1.750 | 2.586.804 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.477.174 | 0,41 | 1,76 | 10.560 | 2.599.826 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.477.174 | 0,41 | 1,76 | 10.560 | 2.599.826 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.100 | 1.471.174 | 0,62 | 1,76 | 16.016 | 2.589.266 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.100 | 1.471.174 | 0,62 | 1,76 | 16.016 | 2.589.266 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.462.074 | 0,69 | 1,76 | 17.600 | 2.573.250 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.462.074 | 0,69 | 1,76 | 17.600 | 2.573.250 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.100 | 1.452.074 | 0,08 | 1,85 | 2.035 | 2.686.337 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.100 | 1.452.074 | 0,08 | 1,85 | 2.035 | 2.686.337 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.450.974 | 0,01 | 1,66 | 332 | 2.408.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.450.974 | 0,01 | 1,66 | 332 | 2.408.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.450.774 | 0,21 | 1,63 | 4.890 | 2.364.762 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.450.774 | 0,21 | 1,63 | 4.890 | 2.364.762 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.447.774 | 0,21 | 1,53 | 4.590 | 2.215.094 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.447.774 | 0,21 | 1,53 | 4.590 | 2.215.094 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.444.774 | 0,07 | 1,52 | 1.520 | 2.196.056 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.444.774 | 0,07 | 1,52 | 1.520 | 2.196.056 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.443.774 | 0,14 | 1,43 | 2.860 | 2.064.597 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.443.774 | 0,14 | 1,43 | 2.860 | 2.064.597 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.441.774 | 0,35 | 1,41 | 7.050 | 2.032.901 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.441.774 | 0,35 | 1,41 | 7.050 | 2.032.901 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.436.774 | 0,35 | 1,47 | 7.350 | 2.112.058 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.436.774 | 0,35 | 1,47 | 7.350 | 2.112.058 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.431.774 | 0,21 | 1,29 | 3.870 | 1.846.988 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.431.774 | 0,21 | 1,29 | 3.870 | 1.846.988 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 900 | 1.428.774 | 0,06 | 1,24 | 1.116 | 1.771.680 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 900 | 1.428.774 | 0,06 | 1,24 | 1.116 | 1.771.680 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.000 | 1.427.874 | 0,28 | 1,53 | 6.120 | 2.184.647 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 4.000 | 1.427.874 | 0,28 | 1,53 | 6.120 | 2.184.647 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.180 | 1.423.874 | 0,22 | 2,30 | 7.314 | 3.274.910 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.180 | 1.423.874 | 0,22 | 2,30 | 7.314 | 3.274.910 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.420.694 | 0,07 | 2,36 | 2.360 | 3.352.838 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.420.694 | 0,07 | 2,36 | 2.360 | 3.352.838 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.419.694 | 0,42 | 2,35 | 14.100 | 3.336.281 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.000 | 1.419.694 | 0,42 | 2,35 | 14.100 | 3.336.281 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.413.694 | 0,21 | 2,33 | 6.990 | 3.293.907 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 3.000 | 1.413.694 | 0,21 | 2,33 | 6.990 | 3.293.907 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.410.694 | 0,36 | 2,44 | 12.200 | 3.442.093 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.410.694 | 0,36 | 2,44 | 12.200 | 3.442.093 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.405.694 | 0,14 | 2,61 | 5.220 | 3.668.861 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.405.694 | 0,14 | 2,61 | 5.220 | 3.668.861 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.403.694 | 0,36 | 2,50 | 12.500 | 3.509.235 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.403.694 | 0,36 | 2,50 | 12.500 | 3.509.235 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 18.000 | 1.398.694 | 1,30 | 2,59 | 46.620 | 3.622.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 18.000 | 1.398.694 | 1,30 | 2,59 | 46.620 | 3.622.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.380.694 | 0,07 | 2,54 | 2.540 | 3.506.963 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.380.694 | 0,07 | 2,54 | 2.540 | 3.506.963 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.379.694 | 0,04 | 2,62 | 1.310 | 3.614.798 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 500 | 1.379.694 | 0,04 | 2,62 | 1.310 | 3.614.798 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.379.194 | 0,01 | 2,52 | 252 | 3.475.569 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.379.194 | 0,01 | 2,52 | 252 | 3.475.569 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 8.500 | 1.379.094 | 0,62 | 2,58 | 21.930 | 3.558.063 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 8.500 | 1.379.094 | 0,62 | 2,58 | 21.930 | 3.558.063 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 22.600 | 1.370.594 | 1,68 | 2,62 | 59.212 | 3.590.956 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 22.600 | 1.370.594 | 1,68 | 2,62 | 59.212 | 3.590.956 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.347.994 | 0,75 | 2,41 | 24.100 | 3.248.666 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 10.000 | 1.347.994 | 0,75 | 2,41 | 24.100 | 3.248.666 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.400 | 1.337.994 | 0,48 | 2,43 | 15.552 | 3.251.325 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.400 | 1.337.994 | 0,48 | 2,43 | 15.552 | 3.251.325 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.331.594 | 0,05 | 2,47 | 1.482 | 3.289.037 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.331.594 | 0,05 | 2,47 | 1.482 | 3.289.037 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.200 | 1.330.994 | 0,47 | 2,23 | 13.826 | 2.968.117 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 6.200 | 1.330.994 | 0,47 | 2,23 | 13.826 | 2.968.117 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -145.788 | 1.250.000 | -10,44 | 11,50 | -1.676.562 | 14.375.000 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -145.788 | 1.250.000 | -10,44 | 11,50 | -1.676.562 | 14.375.000 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -605 | 1.395.788 | -0,04 | 11,65 | -7.048 | 16.260.930 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -605 | 1.395.788 | -0,04 | 11,65 | -7.048 | 16.260.930 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -22.707 | 1.396.393 | -1,60 | 11,34 | -257.497 | 15.835.097 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -22.707 | 1.396.393 | -1,60 | 11,34 | -257.497 | 15.835.097 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -3.500 | 1.419.100 | -0,25 | 10,88 | -38.080 | 15.439.808 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -3.500 | 1.419.100 | -0,25 | 10,88 | -38.080 | 15.439.808 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -20.000 | 1.422.600 | -1,39 | 10,76 | -215.200 | 15.307.176 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -20.000 | 1.422.600 | -1,39 | 10,76 | -215.200 | 15.307.176 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -210.311 | 1.442.600 | -12,72 | 10,18 | -2.140.966 | 14.685.668 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -210.311 | 1.442.600 | -12,72 | 10,18 | -2.140.966 | 14.685.668 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -15.183 | 1.652.911 | -0,91 | 9,70 | -147.275 | 16.033.237 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -15.183 | 1.652.911 | -0,91 | 9,70 | -147.275 | 16.033.237 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -4.200 | 1.668.094 | -0,25 | 9,54 | -40.068 | 15.913.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -4.200 | 1.668.094 | -0,25 | 9,54 | -40.068 | 15.913.617 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -200 | 1.672.294 | -0,01 | 9,57 | -1.914 | 16.003.854 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -200 | 1.672.294 | -0,01 | 9,57 | -1.914 | 16.003.854 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -2.120 | 1.672.494 | -0,13 | 9,52 | -20.182 | 15.922.143 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -2.120 | 1.672.494 | -0,13 | 9,52 | -20.182 | 15.922.143 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -6.423 | 2.091.280 | -0,31 | 9,52 | -61.147 | 19.908.986 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -13.600 | 2.097.703 | -0,64 | 9,47 | -128.792 | 19.865.247 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -16.934 | 2.111.303 | -0,80 | 9,27 | -156.978 | 19.571.779 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -18.560 | 2.128.237 | -0,86 | 9,50 | -176.320 | 20.218.252 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -10.000 | 2.146.797 | -0,46 | 9,12 | -91.200 | 19.578.789 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -6.600 | 2.156.797 | -0,31 | 9,11 | -60.126 | 19.648.421 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -20.000 | 2.163.397 | -0,92 | 9,17 | -183.400 | 19.838.350 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -17.100 | 2.183.397 | -0,78 | 9,41 | -160.911 | 20.545.766 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -26.000 | 166.666 | -13,49 | 9,26 | -240.760 | 1.543.327 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.674.614 | 0,12 | 10,23 | 20.460 | 17.131.301 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.674.614 | 0,12 | 10,23 | 20.460 | 17.131.301 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.300 | 1.672.614 | 0,08 | 10,52 | 13.676 | 17.595.899 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.300 | 1.672.614 | 0,08 | 10,52 | 13.676 | 17.595.899 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 20.015 | 1.671.314 | 1,21 | 10,46 | 209.357 | 17.481.944 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 20.015 | 1.671.314 | 1,21 | 10,46 | 209.357 | 17.481.944 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.651.299 | 0,01 | 4,04 | 808 | 6.671.248 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.651.299 | 0,01 | 4,04 | 808 | 6.671.248 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.651.099 | 0,01 | 4,38 | 438 | 7.231.814 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.651.099 | 0,01 | 4,38 | 438 | 7.231.814 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -200 | 1.650.999 | -0,01 | 3,45 | -690 | 5.695.947 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
S - Sale | -200 | 1.650.999 | -0,01 | 3,45 | -690 | 5.695.947 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.651.199 | 0,04 | 3,45 | 2.070 | 5.696.637 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.651.199 | 0,04 | 3,45 | 2.070 | 5.696.637 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.650.599 | 0,04 | 3,39 | 2.034 | 5.595.531 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 600 | 1.650.599 | 0,04 | 3,39 | 2.034 | 5.595.531 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.400 | 1.649.999 | 0,15 | 3,03 | 7.272 | 4.999.497 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.400 | 1.649.999 | 0,15 | 3,03 | 7.272 | 4.999.497 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.647.599 | 0,12 | 2,97 | 5.940 | 4.893.369 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.647.599 | 0,12 | 2,97 | 5.940 | 4.893.369 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 700 | 1.645.599 | 0,04 | 2,80 | 1.960 | 4.607.677 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 700 | 1.645.599 | 0,04 | 2,80 | 1.960 | 4.607.677 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.644.899 | 0,12 | 2,68 | 5.360 | 4.408.329 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.644.899 | 0,12 | 2,68 | 5.360 | 4.408.329 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 8.000 | 1.642.899 | 0,49 | 2,66 | 21.280 | 4.370.111 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 8.000 | 1.642.899 | 0,49 | 2,66 | 21.280 | 4.370.111 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.634.899 | 0,01 | 2,13 | 426 | 3.482.335 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 200 | 1.634.899 | 0,01 | 2,13 | 426 | 3.482.335 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.634.699 | 0,01 | 2,34 | 234 | 3.825.196 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.634.699 | 0,01 | 2,34 | 234 | 3.825.196 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.634.599 | 0,12 | 1,97 | 3.940 | 3.220.160 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.634.599 | 0,12 | 1,97 | 3.940 | 3.220.160 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.632.599 | 0,12 | 2,21 | 4.420 | 3.608.044 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.632.599 | 0,12 | 2,21 | 4.420 | 3.608.044 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.500 | 1.630.599 | 0,59 | 1,88 | 17.860 | 3.065.526 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 9.500 | 1.630.599 | 0,59 | 1,88 | 17.860 | 3.065.526 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.621.099 | 0,31 | 2,00 | 10.000 | 3.242.198 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.621.099 | 0,31 | 2,00 | 10.000 | 3.242.198 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.616.099 | 0,12 | 1,87 | 3.740 | 3.022.105 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 2.000 | 1.616.099 | 0,12 | 1,87 | 3.740 | 3.022.105 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.614.099 | 0,06 | 2,02 | 2.020 | 3.260.480 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.614.099 | 0,06 | 2,02 | 2.020 | 3.260.480 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.613.099 | 0,06 | 2,04 | 2.040 | 3.290.722 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.000 | 1.613.099 | 0,06 | 2,04 | 2.040 | 3.290.722 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.612.099 | 0,31 | 2,09 | 10.450 | 3.369.287 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 5.000 | 1.612.099 | 0,31 | 2,09 | 10.450 | 3.369.287 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.607.099 | 0,44 | 2,06 | 14.420 | 3.310.624 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 7.000 | 1.607.099 | 0,44 | 2,06 | 14.420 | 3.310.624 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.600.099 | 0,01 | 2,11 | 211 | 3.376.209 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 100 | 1.600.099 | 0,01 | 2,11 | 211 | 3.376.209 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.100 | 1.599.999 | 0,70 | 2,01 | 22.311 | 3.215.998 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 11.100 | 1.599.999 | 0,70 | 2,01 | 22.311 | 3.215.998 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.600 | 1.588.899 | 0,10 | 2,12 | 3.392 | 3.368.466 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 1.600 | 1.588.899 | 0,10 | 2,12 | 3.392 | 3.368.466 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 400 | 1.587.299 | 0,03 | 2,14 | 856 | 3.396.820 | |
2018-03-29 |
|
4 | FENC |
FENNEC PHARMACEUTICALS INC.
Common Stock |
P - Purchase | 400 | 1.587.299 | 0,03 | 2,14 | 856 | 3.396.820 | |
2017-08-01 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
P - Purchase | 5.664.690 | 5.664.690 | 0,66 | 3.738.695 | 3.738.695 | ||
2017-08-01 |
|
4 | MODD |
Modular Medical, Inc.
Common Stock, par value $0.001 per share |
J - Other | -2.900.000 | 0 | -100,00 | 0,13 | -377.000 | ||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2017-05-05 | 3 | BLKE |
BEAR LAKE RECREATION INC
Common Stock, par value $0.001 per share. |
8.700.000 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
11.142.861 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
10.000.003 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
11.142.861 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
10.000.003 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
11.142.861 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
10.000.003 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
11.142.861 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
10.000.003 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
11.142.861 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
10.000.003 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2015-09-29 | 3 | ZMTP |
Zoom Telephonics, Inc.
Common Stock, $0.01 par value |
7.285.718 | ||||||||
2013-11-27 | 3 | ADHXF |
ADHEREX TECHNOLOGIES INC
Common Stock |
2.933.650 | ||||||||
2013-11-27 | 3 | ADHXF |
ADHEREX TECHNOLOGIES INC
Common Stock |
1.981.000 | ||||||||
2013-11-27 | 3 | ADHXF |
ADHEREX TECHNOLOGIES INC
Common Stock |
328.000 | ||||||||
2013-11-27 | 3 | ADHXF |
ADHEREX TECHNOLOGIES INC
Common Stock |
250.000 | ||||||||
2012-10-26 | 3 | NTS |
NTS, INC.
Common Stock |
824.057 | ||||||||
2012-10-26 | 3 | NTS |
NTS, INC.
Common Stock |
1.875.406 |